Quality of life in patients with urticaria

被引：0

作者：

Weldon, DR ^{[1
]}

机构：

[1] Texas A&M Univ, Hlth Sci Ctr, Dept Allergy & Pulm Sci, Scott & White Clin, College Stn, TX 77840 USA

来源：

ALLERGY AND ASTHMA PROCEEDINGS | 2006年 / 27卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Patients with chronic urticaria have a poor quality of life QOL). Chronic pruritus with variable appearance of urticaria and/or angioedema are typical of the uncertainty that compromise their QOL. Other issues such as fatigue, cost of therapy, and social isolation further contribute to the frustration that patients experience. Various instruments are available to measure the quality of life of patients with urticaria and can be adjunctive in the continued assessment of patients with this variable condition. In comparison with other dermatological and medical conditions, patients with chronic urticaria have a significantly worse QOL.

引用

收藏

页码：96 / 99

页数：4

相关论文

共 24 条

[1] Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy [J].

Baiardini, I ;

Giardini, A ;

Pasquali, M ;

Dignetti, P ;

Guerra, L ;

Specchia, C ;

Braido, F ;

Majani, G ;

Canonica, GW .

ALLERGY, 2003, 58 (07) :621-623

[2] A new tool to evaluate the impact of chronic urticaria on quality of life:: chronic urticaria quality of life questionnaire (CU-Q2oL) [J].

Baiardini, I ;

Pasquali, M ;

Braido, F ;

Fumagalli, F ;

Guerra, L ;

Compalati, E ;

Braga, M ;

Lombardi, C ;

Fassio, O ;

Canonica, GW .

ALLERGY, 2005, 60 (08) :1073-1078

[3]

Darsow U., 2004, Journal of Allergy and Clinical Immunology, V113, pS296, DOI 10.1016/j.jaci.2004.01.545

[4] Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria [J].

Di Lorenzo, G ;

Pacor, ML ;

Mansueto, P ;

Pellitteri, ME ;

Lo Bianco, C ;

Ditta, V ;

Martinelli, N ;

Rini, GB .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :619-625

[5] Cost of atopic dermatitis and eczema in the United States [J].

Ellis, CN ;

Drake, LA ;

Prendergast, MM ;

Abramovits, W ;

Boguniewicz, M ;

Daniel, CR ;

Lebwohl, M ;

Stevens, SR ;

Whitaker-Worth, DL ;

Cheng, JW ;

Tong, KB .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) :361-370

[6]

FINLAY AY, 1996, J EUR ACAD DERMATOL, V7, P149

[7] A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria [J].

Finn, AF ;

Kaplan, AF ;

Fretwell, R ;

Qu, R ;

Long, J .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (05) :1071-1078

[8] Qualitative research-enhanced understanding of patients' beliefs: Results of focus groups with low-income, urban, African American adults with asthma [J].

George, M ;

Freedman, TG ;

Norfleet, AL ;

Feldman, HI ;

Apter, AJ .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 111 (05) :967-973

[9] PROLONGATION OF SIMPLE AND CHOICE REACTION-TIMES IN A DOUBLE-BLIND COMPARISON OF TWICE-DAILY HYDROXYZINE VERSUS TERFENADINE [J].

GOETZ, DW ;

JACOBSON, JM ;

MURNANE, JE ;

REID, MJ ;

REPPERGER, DW ;

GOODYEAR, C ;

MARTIN, ME .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (03) :316-322

[10] Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life [J].

Grob, JJ ;

Revuz, J ;

Ortonne, JP ;

Auquier, P ;

Lorette, G .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (02) :289-295